Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:29:34.790Z.
Calculation as of: 2026-10-06T21:29:34.790Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 62e543f524ee8633d6080f2a553f9cbd6b945788c6a084cb4464cef9d8d253d7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2020-05-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
OPERATING CASH FLOW YIELD AVG TTM
N/A
OPERATING CASH FLOW YIELD AVG 3Y
N/A
OPERATING CASH FLOW YIELD AVG 5Y
N/A
OPERATING CASH FLOW YIELD AVG 10Y
N/A
OPERATING CASH FLOW YIELD AVG 15Y
N/A
OPERATING CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$6.74M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.07M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.12M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.61M
Operating Cash Flow Yield
N/A
TTM Avg
0.85%
3Y Avg
0.85%
5Y Avg
0.85%
Market Cap
$6.60M
Operating Cash Flow Yield
N/A
TTM Avg
1.12%
3Y Avg
0.90%
5Y Avg
0.90%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.04M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | N/A | N/A | N/A | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.15M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.61M | N/A | 0.85% | 0.85% | 0.85% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | N/A | 1.12% | 0.90% | 0.90% |
| Aclarion, Inc. (ACON)vs › | $6.60M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | N/A | 0.05% | 0.04% | 0.03% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING CASH FLOW YIELD |
|---|---|
| 2020-05-14 | 0.15% |
| 2020-05-13 | 0.14% |
| 2020-05-12 | 0.13% |
| 2020-05-11 | 0.13% |
| 2020-05-08 | 0.13% |
| 2020-05-07 | 0.14% |
| 2020-05-06 | 0.14% |
| 2020-05-05 | 0.15% |
| 2020-05-04 | 0.17% |
| 2020-05-01 | 0.18% |
| 2020-04-30 | 0.16% |
| 2020-04-29 | 0.16% |
| 2020-04-28 | 0.16% |
| 2020-04-27 | 0.16% |
| 2020-04-24 | 0.16% |
| 2020-04-23 | 0.16% |
| 2020-04-22 | 0.16% |
| 2020-04-21 | 0.16% |
| 2020-04-20 | 0.17% |
| 2020-04-17 | 0.17% |
| 2020-04-16 | 0.18% |
| 2020-04-15 | 0.18% |
| 2020-04-14 | 0.18% |
| 2020-04-13 | 0.17% |
| 2020-04-09 | 0.18% |
| 2020-04-08 | 0.19% |
| 2020-04-07 | 0.21% |
| 2020-04-06 | 0.24% |
| 2020-04-03 | 0.25% |
| 2020-04-02 | 0.25% |
| 2020-04-01 | 0.24% |
| 2020-03-31 | 0.23% |
| 2020-03-30 | 0.25% |
| 2020-03-27 | 0.26% |
| 2020-03-26 | 0.25% |
| 2020-03-25 | 0.28% |
| 2020-03-24 | 0.32% |
| 2020-03-23 | 0.32% |
| 2020-03-20 | 0.33% |
| 2020-03-19 | 0.33% |
| 2020-03-18 | 0.33% |
| 2020-03-17 | 0.27% |
| 2020-03-16 | 0.30% |
| 2020-03-13 | 0.29% |
| 2020-03-12 | 0.26% |
| 2020-03-11 | 0.21% |
| 2020-03-10 | 0.19% |
